Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Experimental therapy in myelofibrosis with myeloid metaplasia.

Expert opinion on investigational drugs - 1 Dec 2006

Verstovsek Srdan, Quintás-Cardama Alfonso, Kantarjian Hagop, Tefferi Ayalew

Abstract excerpt

Myelofibrosis with myeloid metaplasia (MMM) is a Philadelphia chromosome-negative myeloproliferative disorder that is characterised by constitutional symptoms, progressive anaemia and extramedullary haematopoiesis. There are no curative therapies available for patients with MMM apart from stem cell transplantation, which is associated with significant morbidity and mortality, and for which most patients are not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Chromosomes, Human
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drugs, Investigational

Share to Farnesyltranstransferase

Share to Immunologic Factors

Share to Primary Myelofibrosis

Share to Stromal Cells

Source

Identifiers

PMID: 17107281
DOI: 10.1517/13543784.15.12.1555

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Experimental therapy in myelofibrosis with myeloid metaplasia.PMID 17107281Read ↗

Experimental therapeutics for patients with myeloproliferative neoplasias.Semantic proximity Read ↗

International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).Semantic proximity Read ↗

Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives.Semantic proximity Read ↗

[Recent advances in the treatment of myelofibrosis].Semantic proximity Read ↗

Management of Myelofibrosis: from Diagnosis to New Target Therapies.Semantic proximity Read ↗

Pathogenesis of myelofibrosis with myeloid metaplasia.Semantic proximity Read ↗

How I treat myelofibrosis.Semantic proximity Read ↗

Novel therapies for myelofibrosis.Semantic proximity Read ↗

Myelofibrosis: challenges for preclinical models and emerging therapeutic targets.Semantic proximity Read ↗

Myelofibrosis: an update on current pharmacotherapy and future directions.Semantic proximity Read ↗

[The cutting edge of medicine: pathophysiology and treatment of myeloproliferative neoplasms].Semantic proximity Read ↗

Emerging targeted therapies in myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.